Illnesses and conditions
Medical research, treatments, innovations and advancements related to particular physical conditions, including diabetes, cancers, heart disease, obesity, chronic pain, infectious diseases, allergies and others.
Top News
-
Hugely promising cancer immunotherapy drug dostarlimab is one step closer to being widely available, after the Food and Drug Administration granted it Breakthrough Therapy Designation status that, if successful, will expedite its path to market.
-
Some people can’t get their bad cholesterol levels down, even if they take cholesterol-lowering meds. A clinical trial using a combination of existing and not-yet-released cholesterol tablets lowered bad cholesterol by almost half.
-
An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug that offers 100% protection with its twice-yearly injections. It's a landmark achievement set to save millions of lives.
Load More
Latest News
-
September 16, 2025 | Michael FrancoA new breakthrough removes the dangers involved in a process called STING, in which the body's own immune system can be enlisted to fight cancer. The finding clears the way for a powerful, and safe, weapon against tumors.
-
September 15, 2025 | Bronwyn ThompsonThe US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease patients, aiming to prevent a common and costly issue that results in more than a million hospitalizations each year.
-
September 13, 2025 | Bronwyn ThompsonWhen scientists study obesity, it's often focused on genetics, physical activity and poor eating habits. However, new findings show that stress, hardship, isolation and social inequality create the biological environment that underpins the epidemic.
-
September 13, 2025 | Paul McClureSigns of immune system aging appear years before rheumatoid arthritis takes hold, offering new hope for early diagnosis and treatments that could slow or stop the disease before it starts, according to new research.
-
September 11, 2025 | Bronwyn ThompsonA new drug candidate could become a first-in-class medication, after impressive results in a mid-stage clinical trial for drug-resistant epilepsy. It now moves to Phase 3 trials, raising hope for people who suffer seizures despite being on medication.
-
September 10, 2025 | Bronwyn ThompsonA study has found people living with chronic pain tend to be more perfectionistic, less self-compassionate and – depending on the measure – less confident in their ability to cope. These traits may intensify suffering, but also point to new avenues for relief.
-
September 10, 2025 | Michael FrancoA squishy cartilage-like material has been developed by researchers at the University of Cambridge. It can be loaded up with either long-term or short-term pain killers that are released when the material senses chemical stress from arthritis.
-
September 09, 2025 | Bronwyn ThompsonAustralia's embattled koalas have been given some good news for once, with the approval of the world's first chlamydia vaccine. More than a decade in the making, a single jab will now protect koalas from the disease decimating their populations.
-
September 09, 2025 | Bronwyn ThompsonIn a landmark move, the FDA has given biotech company eGenesis the go-ahead to conduct a wider trial of pig-to-human kidney transplants, marking a significant step forward in addressing the critical organ shortage now facing thousands of Americans.
-
September 06, 2025 | Paul McClureStarting aerobic exercise just two months after a stroke is safe and may help protect thinking skills, according to new research. The study provides fresh hope for stroke survivors that they can reduce their elevated risk of dementia.
-
September 05, 2025 | Pranjal MalewarA new study has presented what is called the Adipokine Hypothesis, suggesting one of the most common forms of heart failure may stem from biological changes in internal fat; sending out chemical signals that stir up inflammation.
-
September 04, 2025 | Bronwyn ThompsonA new drug that significantly lowers "stubborn" blood pressure is on the horizon, following the results of its Phase III clinical trial. The drug, called baxdrostat, is being hailed as the most promising advance in hypertension management in decades.
-
September 03, 2025 | Pranjal MalewarA new study flips the script on hypertension. Long blamed on the kidneys and blood vessels, it now seems the brain might be a silent instigator, especially in cases where standard treatments fail.
-
September 03, 2025 | Bronwyn ThompsonA carotenoid widely available in fruit and vegetables, and as a supplement, has been found to bolster the cancer-killing capacity of immune cells. It could be a valuable ally in immunotherapy treatment, helping to shrink tumors more effectively.
-
August 31, 2025 | Pranjal MalewarWhat we eat, what drugs we take, and even the timing or combination of treatments could influence how bacteria respond to antibiotics. A food ingredient like caffeine or a second medication might tip the balance, making antibiotics less effective.
Load More